European Commission Grants $6M to Develop New Hemophilia A Treatment

December 29, 2015

Note: The following is an edited press release from Sernova Corp. The original release can be read in its entirety here. Sernova Corp., a clinical stage regenerative medicine company, announced on Monday, December 21, 2015, that the European Commission鈥檚 Horizon 2020 program has awarded a Euro 5.6M ($6.1M USD) grant to a consortium consisting of […]

Sign up for E-mails, Dateline Magazine, and other ways to stay connected.